MOR Annual CFI
$16.64 M
-$347.19 M-95.43%
31 December 2023
Summary:
As of January 30, 2025, MOR annual cash flow from investing activities is $16.64 million, with the most recent change of -$347.19 million (-95.43%) on December 31, 2023. During the last 3 years, it has risen by +$1.02 billion (+101.66%).MOR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MOR Quarterly CFI
N/A
31 December 2023
Summary:
MOR quarterly cash flow from investing activities is not available.MOR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MOR TTM CFI
N/A
31 December 2023
Summary:
MOR TTM cash flow from investing activities is not available.MOR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MOR Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -95.4% | - | - |
| 3 y3 years | +101.7% | - | - |
| 5 y5 years | +107.9% | - | - |
MOR Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -95.4% |
MorphoSys AG Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $16.64 M(-95.4%) | - | - |
| June 2023 | - | $25.51 M(+140.4%) | $36.13 M(-67.0%) |
| Mar 2023 | - | $10.61 M(-89.2%) | $109.31 M(-109.9%) |
| Dec 2022 | $363.84 M(-137.0%) | - | - |
| June 2022 | - | $98.70 M(-23.6%) | -$1.11 B(+23.9%) |
| Mar 2022 | - | $129.25 M(+578.1%) | -$893.98 M(-9.1%) |
| Dec 2021 | -$983.23 M(-2.1%) | $19.06 M(-101.4%) | -$983.23 M(-20.0%) |
| Sept 2021 | - | -$1.36 B(-533.2%) | -$1.23 B(-862.0%) |
| June 2021 | - | $312.79 M(+682.0%) | $161.29 M(-116.7%) |
| Mar 2021 | - | $40.00 M(-117.6%) | -$964.56 M(-4.0%) |
| Dec 2020 | -$1.00 B(-1228.9%) | -$226.78 M(-742.8%) | -$1.00 B(+34.4%) |
| Sept 2020 | - | $35.28 M(-104.3%) | -$747.50 M(-4.9%) |
| June 2020 | - | -$813.05 M(-2785.7%) | -$785.90 M(-983.2%) |
| Dec 2019 | $88.98 M(-142.4%) | $30.27 M(-1069.3%) | $88.98 M(-2258.6%) |
| Sept 2019 | - | -$3.12 M(-110.1%) | -$4.12 M(-109.3%) |
| June 2019 | - | $30.95 M(+0.2%) | $44.19 M(-123.6%) |
| Mar 2019 | - | $30.88 M(-149.1%) | -$187.17 M(-10.8%) |
| Dec 2018 | -$209.89 M(-662.8%) | -$62.83 M(-239.0%) | -$209.89 M(+31.6%) |
| Sept 2018 | - | $45.19 M(-122.5%) | -$159.47 M(-5.0%) |
| June 2018 | - | -$200.41 M(-2555.1%) | -$167.91 M(+1669.6%) |
| Mar 2018 | - | $8.16 M(-165.8%) | -$9.49 M(-125.4%) |
| Dec 2017 | $37.30 M(-141.7%) | -$12.41 M(-133.8%) | $37.30 M(-780.2%) |
| Sept 2017 | - | $36.75 M(-187.5%) | -$5.48 M(-92.2%) |
| June 2017 | - | -$42.00 M(-176.4%) | -$70.73 M(-22.8%) |
| Mar 2017 | - | $54.95 M(-199.6%) | -$91.67 M(+2.5%) |
| Dec 2016 | -$89.41 M(-193.4%) | -$55.19 M(+93.7%) | -$89.41 M(-254.2%) |
| Sept 2016 | - | -$28.50 M(-54.7%) | $57.97 M(-2.8%) |
| June 2016 | - | -$62.93 M(-210.0%) | $59.65 M(-61.4%) |
| Mar 2016 | - | $57.20 M(-38.0%) | $154.43 M(+61.3%) |
| Dec 2015 | $95.73 M | $92.19 M(-443.8%) | $95.73 M(-346.3%) |
| Sept 2015 | - | -$26.82 M(-184.2%) | -$38.86 M(-545.0%) |
| June 2015 | - | $31.86 M(-2226.6%) | $8.73 M(-149.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | -$1.50 M(-96.5%) | -$17.67 M(-38.2%) |
| Dec 2014 | -$28.59 M(-88.9%) | -$42.40 M(-304.1%) | -$28.59 M(+70.0%) |
| Sept 2014 | - | $20.78 M(+281.1%) | -$16.82 M(-93.8%) |
| June 2014 | - | $5.45 M(-143.9%) | -$270.69 M(+6.5%) |
| Mar 2014 | - | -$12.42 M(-59.5%) | -$254.15 M(-1.3%) |
| Dec 2013 | -$257.46 M(+1556.2%) | -$30.63 M(-86.9%) | -$257.46 M(+11.6%) |
| Sept 2013 | - | -$233.09 M(-1160.1%) | -$230.73 M(-6473.7%) |
| June 2013 | - | $21.99 M(-239.9%) | $3.62 M(-159.3%) |
| Mar 2013 | - | -$15.72 M(+303.0%) | -$6.10 M(-60.7%) |
| Dec 2012 | -$15.54 M(-38.4%) | -$3.90 M(-411.0%) | -$15.54 M(+11.5%) |
| Sept 2012 | - | $1.25 M(-89.8%) | -$13.94 M(+9.6%) |
| June 2012 | - | $12.27 M(-148.7%) | -$12.71 M(-70.1%) |
| Mar 2012 | - | -$25.16 M(+997.1%) | -$42.57 M(+68.8%) |
| Dec 2011 | -$25.23 M(+853.5%) | -$2.29 M(-192.5%) | -$25.23 M(+89.6%) |
| Sept 2011 | - | $2.48 M(-114.1%) | -$13.31 M(-334.6%) |
| June 2011 | - | -$17.59 M(+124.9%) | $5.67 M(+185.2%) |
| Mar 2011 | - | -$7.82 M(-181.3%) | $1.99 M(-175.1%) |
| Dec 2010 | -$2.65 M(-403.2%) | $9.63 M(-55.1%) | -$2.65 M(-81.3%) |
| Sept 2010 | - | $21.46 M(-200.9%) | -$14.14 M(-50.7%) |
| June 2010 | - | -$21.27 M(+70.8%) | -$28.68 M(+37.9%) |
| Mar 2010 | - | -$12.46 M(+565.7%) | -$20.80 M(-2484.0%) |
| Dec 2009 | $872.60 K(-101.5%) | -$1.87 M(-127.1%) | $872.50 K(-68.2%) |
| Sept 2009 | - | $6.92 M(-151.7%) | $2.74 M(-165.7%) |
| June 2009 | - | -$13.39 M(-245.3%) | -$4.17 M(-145.3%) |
| Mar 2009 | - | $9.22 M | $9.22 M |
| Dec 2008 | -$57.70 M(+715.0%) | - | - |
| Dec 2007 | -$7.08 M(-84.4%) | - | - |
| Dec 2006 | -$45.46 M(+16.4%) | - | - |
| Dec 2005 | -$39.07 M(+238.2%) | - | - |
| Dec 2004 | -$11.55 M(-599.2%) | - | - |
| Dec 2003 | $2.31 M(-120.6%) | - | - |
| Dec 2002 | -$11.25 M | - | - |
FAQ
- What is MorphoSys AG annual cash flow from investing activities?
- What is the all time high annual CFI for MorphoSys AG?
- What is MorphoSys AG annual CFI year-on-year change?
- What is the all time high quarterly CFI for MorphoSys AG?
- What is the all time high TTM CFI for MorphoSys AG?
What is MorphoSys AG annual cash flow from investing activities?
The current annual CFI of MOR is $16.64 M
What is the all time high annual CFI for MorphoSys AG?
MorphoSys AG all-time high annual cash flow from investing activities is $363.84 M
What is MorphoSys AG annual CFI year-on-year change?
Over the past year, MOR annual cash flow from investing activities has changed by -$347.19 M (-95.43%)
What is the all time high quarterly CFI for MorphoSys AG?
MorphoSys AG all-time high quarterly cash flow from investing activities is $312.79 M
What is the all time high TTM CFI for MorphoSys AG?
MorphoSys AG all-time high TTM cash flow from investing activities is $161.29 M